コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ng between part-solid (PS) and nonsolid (NS) lung nodules.
2 o be helpful in the identification of benign lung nodules.
3 t with the characterization of indeterminate lung nodules.
4 d left parietal CNS metastasis and enlarging lung nodules.
5 s, including high concentrations in lymphoid lung nodules.
6 OPG and anti-gp100 (HMB45) antibodies in LAM lung nodules.
7 (CT)-guided percutaneous tissue sampling of lung nodules.
8 uted tomographic (CT) volumetric analysis of lung nodules.
9 ated variables involved in the assessment of lung nodules.
10 99 localizes rapidly and specifically to B16 lung nodules.
11 , thus improving the diagnostic accuracy for lung nodules.
12 There were 51 cases with and 49 without lung nodules.
13 was applied to data from 15 subjects with 77 lung nodules.
14 olorectal cancer, and 1 lymphoma) and 7 with lung nodules.
15 21-89 years old (mean age, 61.3 years) with lung nodules 1.0 cm or smaller underwent CT-guided trans
19 employed in a bakery presented with a single lung nodule and underwent investigations to rule out pul
20 y be useful in identifying the derivation of lung nodules and consequently enhances treatment plannin
21 ease in which LAM cells and fibroblasts form lung nodules and it is hypothesized that LAM nodule-deri
23 he same year she was diagnosed with multiple lung nodules and underwent pulmonary wedge resection wit
24 , and one of the features for liver lesions, lung nodules, and renal stones, respectively (P < .002 f
25 1, and 15 of the features for liver lesions, lung nodules, and renal stones, respectively (P < .002 f
26 and four of the features for liver lesions, lung nodules, and renal stones, respectively (P < .002 f
28 died in lung blood vessels, producing as few lung nodules as B16-FTIII.N cells which lack sialyl Lewi
33 Histologically, CD44v6 was present in LAM lung nodules, but not in normal vascular smooth muscle c
41 e-matched smokers or individuals with benign lung nodules correctly classified 95% of patients (AUCs
43 ce of focal tracer uptake was noted for each lung nodule detected on (18)F-FDG PET/CT and (18)F-FDG P
44 to accurately estimate the probability that lung nodules detected on baseline screening low-dose CT
46 mine factors predicting the probability that lung nodules detected on the first screening low-dose CT
48 3, P < .01 for group 2), with higher CNR for lung nodule detection (12.1 +/- 1.7 vs 10.0 +/- 1.8, P <
49 performed conventional chest radiography for lung nodule detection and determination of case manageme
52 rch, recognition and acceptance, and overall lung nodule detection rate can be studied with eye track
54 within the GV gaze volume s, the fraction of lung nodules encompassed within each GV gaze volume (sea
56 al applications of lung cancer screening and lung nodule evaluation, the policy statement outlines ca
60 lung nodules greater than 300 mm(3), and new lung nodules greater than 200 mm(3), should be managed i
61 eening approach; that non-calcified baseline lung nodules greater than 300 mm(3), and new lung nodule
62 lcified lung nodules <1 cm, 12 patients with lung nodules > or =1 cm, 24 patients with infiltrates, 7
63 showed that the right ureteral mass and all lung nodules had regressed or disappeared (Figs 2B, 3B).
65 Purpose To determine whether the pattern of lung nodules in children with metastatic hepatoblastoma
66 surement of subcutaneous tumors, of counting lung nodules in metastasis models, and the indirect natu
67 computer-aided diagnostic (CAD) research for lung nodules in thoracic computed tomography (CT), the N
68 s distributed nonuniformly across four small lung nodules, including high levels of EEHV6, lower leve
71 1998 and 2001, 128 patients with peripheral lung nodules < or = 3 cm in size with suspected NSCLC we
72 These included 53 patients with noncalcified lung nodules <1 cm, 12 patients with lung nodules > or =
74 et up to oversee technical standards; that a lung nodule management pathway should be established and
75 re on volumetry and volume doubling times in lung nodule management, outlining their benefits and dra
77 st CT detected an additional 125 parenchymal lung nodules (mean size, 3.4 +/- 1.6 mm; range, 1-9 mm)
80 wed, and information was collected regarding lung nodule number, size, laterality, timing of resoluti
83 ariations surrounding and overlying a subtle lung nodule on a chest radiograph that are created by th
85 diologists' performance for the detection of lung nodules on chest radiographs, even when baseline pe
90 es or masses depicted at PET, 13 (93%) of 14 lung nodules or masses, 20 (65%) of 31 mediastinal lymph
92 the utility of percutaneous localization of lung nodules performed in conjunction with video-assiste
94 ET/MRI than (18)F-FDG PET/CT regarding small lung nodules should be considered in the staging of mali
98 ve detection and characterization of smaller lung nodules, thus increasing the chances of positive tr
103 , and LNCaP cells, however the volume of the lung nodules was less than 1 mm3 in all of the cases.
104 A database of 38 low-dose CT scans with 50 lung nodules was obtained from a lung cancer screening p
106 r after baseline scanning, 2,244 uncalcified lung nodules were identified in 1,000 participants (66%)
107 ive annual CT examinations, 3356 uncalcified lung nodules were identified in 1118 (74%) participants.
108 (CD) that emulated subtle tissue-equivalent lung nodules were numerically superimposed at the center
111 ignificantly enhanced antimetastatic effect: lung nodules were reduced by 7- to 24-fold by Cellax tre
114 Data from 311 consecutive patients with lung nodules who underwent (18)F-FDG PET/CT and CT-guide
115 etric measurement error in the assessment of lung nodules with CT would be a first step toward the de
116 lume (search effectiveness), the fraction of lung nodules within the GV gaze volume detected by the r
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。